Anti-hypertensive agents in older adults: A systematic Review and Meta-analysis of Randomized Clinical Trials.

CONCLUSIONS: Individuals aged 65 years and older or 75 years and older who receive anti-hypertensive therapy have statistically significant reduction in the risk of all-cause and cardiovascular mortality, heart failure and stroke. There was no statistically significant difference in estimates between those with, and without DM.
PMID: 30903690 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - March 22, 2019 Category: Endocrinology Authors: Murad MH, Larrea-Mantilla L, Haddad A, Spencer-Bonilla G, Serrano V, Rodriguez-Gutierrez R, Alvarez-Villalobos N, Benkhadra K, Gionfriddo MR, Prokop LJ, Brito JP, Ponce OJ Tags: J Clin Endocrinol Metab Source Type: research